home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Host Of New Genes Spotted

  October, 31 2007 20:26
your information resource in human molecular genetics
Scientists have uncovered a complex network of genes involved in the conversion of normal cells to cancerous ones - potentially opening up a range of new strategies for developing drugs to tackle the disease.

The research, described in Nature by Michael Green and his colleagues, investigates the changes that are needed to make cells cancerous. Cancer cells' runaway growth arises partly from the 'silencing' of certain genes. In this study, cultured cells that have the same genetic changes as cancer cells in the body were screened for genes necessary to silence another gene Fas, which in healthy tissues ensures that cells die off when necessary, rather than growing out of control, and is silenced by Ras. They identified 28 genes, termed 'Ras epigenetic silencing factors', with a range of different functions; these genes comprise a common pathway that suppresses expression of Fas.


Michael Green (University of Massachusetts Medical School, Worcester, MA, USA)
E-mail: michael.green@umassmed.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.